![]() |
Exemestane May Be Another First-Line, Adjuvant Therapy For Hormone-Receptor Positive,
Exemestane, an aromatase inhibitor that blocks production of estrogen, may provide another post-surgery option for postmenopausal women with hormone-receptor positive, early-stage breast cancer...
More... |
| All times are GMT -7. The time now is 11:40 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021